The scientific view sees diabetes as a disease of insulin dysfunction: either the body stops producing it or cells stop responding to it. Research has uncovered that inflammation in fat tissue contributes to insulin resistance, linking metabolic health to immune responses. This has opened new paths for treatments targeting inflammation and insulin pathways to better control or prevent diabetes.